A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: Blood-derived endothelial progenitor cells

Imbisaat Geti, Mark L. Ormiston, Foad Rouhani, Mark Toshner, Mehregan Movassagh, Jennifer Nichols, William Mansfield, Mark Southwood, Allan Bradley, Amer Ahmed Rana, Ludovic Vallier, Nicholas W. Morrell

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)

Abstract

Induced pluripotent stem cells (iPSCs) have the potential to generate patient-specific tissues for disease modeling and regenerative medicine applications. However, before iPSC technology can progress to the translational phase, several obstacles must be overcome. These include uncertainty regarding the ideal somatic cell type for reprogramming, the low kinetics and efficiency of reprogramming, and karyotype discrepancies between iPSCs and their somatic precursors. Here we describe the use of late-outgrowth endothelial progenitor cells (L-EPCs), which possess several favorable characteristics, as a cellular substrate for the generation of iPSCs.Wehave developed a protocol that allows the reliable isolation of L-EPCs from peripheral blood mononuclear cell preparations, including frozen samples. As a proof-of-principle for clinical applications we generated EPC-iPSCs from both healthy individuals and patients with heritable and idiopathic forms of pulmonary arterial hypertension. L-EPCs grew clonally; were highly proliferative, passageable, and bankable; and displayed higher reprogramming kinetics and efficiencies compared with dermal fibroblasts. Unlike fibroblasts, the high efficiency of L-EPC reprogramming allowed for the reliable generation of iPSCs in a 96-well format, which is compatible with high-throughput platforms. Array comparative genome hybridization analysis of L-EPCs versus donor-matched circulating monocytes demonstrated that L-EPCs have normal karyotypes compared with their subject's reference genome. In addition, >80% of EPC-iPSC lines tested did not acquire any copy number variations during reprogramming compared with their parent L-EPC line. This work identifies L-EPCs as a practical and efficient cellular substrate for iPSC generation, with the potential to address many of the factors currently limiting the translation of this technology.

Original languageEnglish
Pages (from-to)855-865
Number of pages11
JournalStem Cells Translational Medicine
Volume1
Issue number12
DOIs
Publication statusPublished - 2012

Keywords

  • Direct cell conversion
  • Endothelial cell
  • Induced pluripotent stem cells
  • Progenitor cells
  • Reprogramming

Cite this